Rothschild Investment LLC’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-54,646
Closed -$3.5M 388
2018
Q4
$3.5M Sell
54,646
-21,498
-28% -$1.59M 0.47% 63
2018
Q3
$6.81M Sell
76,144
-300
-0.4% -$26.5K 0.8% 38
2018
Q2
$6.07M Buy
76,444
+170
+0.2% +$14.1K 0.76% 38
2018
Q1
$6.8M Sell
76,274
-13,223
-15% -$1.27M 0.87% 34
2017
Q4
$9.34M Buy
89,497
+5,300
+6% +$598K 1.01% 27
2017
Q3
$12.3M Sell
84,197
-121
-0.1% -$16.5K 1.39% 10
2017
Q2
$10.9M Buy
84,318
+673
+0.8% +$82.5K 1.24% 14
2017
Q1
$10.4M Buy
83,645
+431
+0.5% +$51.6K 1.21% 15
2016
Q4
$9.63M Sell
83,214
-3,141
-4% -$350K 1.16% 17
2016
Q3
$9.03M Sell
86,355
-1,243
-1% -$135K 1.11% 20
2016
Q2
$8.64M Buy
87,598
+285
+0.3% +$29.5K 1.1% 19
2016
Q1
$8.74M Buy
87,313
+245
+0.3% +$25.2K 1.12% 19
2015
Q4
$10.4M Buy
87,068
+1,771
+2% +$205K 1.33% 8
2015
Q3
$9.23M Sell
85,297
-18,468
-18% -$2.29M 1.22% 10
2015
Q2
$12M Buy
103,765
+384
+0.4% +$43.9K 1.39% 8
2015
Q1
$11.9M Buy
103,381
+540
+0.5% +$64.5K 1.39% 10
2014
Q4
$11.5M Sell
102,841
-10,783
-9% -$1.14M 1.37% 12
2014
Q3
$10.8M Buy
113,624
+15,492
+16% +$1.4M 1.31% 12
2014
Q2
$8.43M Buy
98,132
+6,828
+7% +$519K 1.08% 15
2014
Q1
$6.37M Buy
91,304
+82,380
+923% +$6.52M 0.86% 26
2013
Q4
$754K Hold
8,924
0.1% 209
2013
Q3
$688K Sell
8,924
-780
-8% -$54.7K 0.1% 201
2013
Q2
$568K Buy
+9,704
New +$584K 0.09% 211

Other funds holding CELG

Rothschild Investment LLC's CELG Position: Q1 2019 in Review

Rothschild Investment LLC sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 54,646 shares — an estimated $3.5M sold.

Rothschild Investment LLC first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $12.3M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Rothschild Investment LLC reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Rothschild Investment LLC sold 54,646 Celgene Corp shares in Q1 2019, an estimated $3.5M.
  • Rothschild Investment LLC first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Rothschild Investment LLC's Celgene Corp position peaked at $12.3M in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Rothschild Investment LLC's 13F filing for Q1 2019, filed 18 Apr 2019.